Item 2.02    Results of Operations and Financial Condition
The Company announced its results of operations for the three months ended June
30, 2021 in a press release dated August 3, 2021, that is attached and
incorporated herein by reference as Exhibit 99.1.
The information, including the exhibit attached hereto in Item 2.02 of this
Current Report is being furnished and shall not be deemed "filed" for the
purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or
otherwise subject to the liabilities of that Section. The information in Item
2.02 of this Current Report shall not be incorporated by reference into any
registration statement or other document pursuant to the Securities Act of 1933,
as amended, except as otherwise expressly stated in such filing.
Item 5.02(b)    Departure of Directors or Certain Officers; Election of
Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain
Officers
On July 29, 2021, Heidi Kunz notified the Company that she was resigning from
the Board of Directors to pursue other business opportunities. There were no
disagreements between Ms. Kunz and the Company.
Item 9.01    Financial Statements and Exhibits
(d)Exhibits.

The following exhibits are filed with this Current Report on Form 8-K:


 Exhibit No.                                  Description
     99.1           Press Release issued by Avanos Medical, Inc. on August 3, 2021
   101.SCH        XBRL Taxonomy Extension Schema Document
   101.CAL        XBRL Taxonomy Extension Calculation Linkbase Document
   101.DEF        XBRL Taxonomy Extension Definition Linkbase Document
   101.LAB        XBRL Taxonomy Extension Label Linkbase Document
   101.PRE        XBRL Taxonomy Extension Presentation Linkbase Document

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses